Saturday, July 4, 2026

Search
HomeBusiness NewsTelix Pharmaceuticals Q1 2026: Revenue growth, guidance reaffirmed
Business News

Telix Pharmaceuticals Q1 2026: Revenue growth, guidance reaffirmed

0
5
- Advertisement -


The Telix Pharmaceuticals Ltd (ASX: TLX) share price is in focus after the company reported group revenue of US$230 million, up 11% quarter-over-quarter, and reaffirmed its FY 2026 revenue guidance.

Image source: Getty Images

What did Telix Pharmaceuticals report?

  • Unaudited group revenue of…



Click here to view the original article.

- Advertisment -
Previous article
Farmers push for stronger protections in renewable energy benefit policy
Next article
Bradley Roberts-Smith arrested; WA fuel stocks improve; Petrol stations fined; Boy dies after scooter crash

RELATED ARTICLES

- Advertisement -

Recently Viewed

Load more

FEATURED

POPULAR POSTS

POPULAR CATEGORY

The Australian Online News Network acknowledges the traditional custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.

FOLLOW US

© 2024 Australian Online News | Privacy Policy